GOLDSMITH MARK A sold RVMD
March 2, 2026 · Form 4 insider transaction
GOLDSMITH MARK A sold 21,329 shares of Revolution Medicines, Inc. at $101.60 per share, a transaction worth $2.17M. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 1 day after the transaction.
Footnotes
Transaction made pursuant to a 10b5-1 trading plan adopted by Mark A. Goldsmith on December 19, 2024.; This transaction was executed in multiple trades at prices ranging from $101.14 to $102.11. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.; Includes 225,863 restricted stock units.